Recombinant FGL1 抗体 (AA 18-312)
Our Local Distributor
北京 101111
Quick Overview for Recombinant FGL1 抗体 (AA 18-312) (ABIN7453972)
抗原
See all FGL1 抗体抗体类型
适用
宿主
克隆类型
标记
应用范围
克隆位点
-
-
抗原表位
- AA 18-312
-
原理
- Rabbit anti-Hepassocin/FGL1 Recombinant Monoclonal Antibody [BLR210K] - BSA-Free
-
纯化方法
- Purified
-
免疫原
- residues 18-312 (full length)
-
亚型
- IgG
-
-
-
-
应用备注
- Optimal working dilution should be determined by the investigator.
-
限制
- 仅限研究用
-
-
-
状态
- Liquid
-
浓度
- 1000 μg/mL
-
缓冲液
- Borate Buffered Saline (BBS) pH 8.2 with 0.09 % Sodium Azide, BSA-Free
-
储存液
- Sodium azide
-
注意事项
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
储存条件
- 4 °C
-
储存方法
- 2 - 8 °C
-
有效期
- 12 months
-
-
- FGL1 (Fibrinogen-Like 1 (FGL1))
-
别名
- Hepassocin/FGL1
-
背景
- Hepassocin, also known as Fibrinogen-like 1 (FGL1), is a member of the fibrinogen family whose members share a fibrinogen domain at their C-termini. However, it lacks the platelet-binding site, cross-linking region and thrombin-sensitive site which are necessary for fibrin clot formation. Hepassocin/FGL1 is secreted by hepatocytes and may play a role in the development of hepatocellular carcinomas. Hepassocin/FGL1 is an immune suppressive molecule that inhibits antigen-specific T-cell activation by acting as a major ligand of LAG3 [taken from NCBI Entrez Gene (Gene ID: 2267)].
-
基因ID
- 2267
-
UniProt
- Q08830
抗原
-